# Augmented reality and radiology: visual enhancement or monopolized mirage

## TL;DR

This paper explores how augmented reality could change radiology but warns about the risks of big tech companies controlling the technology.

## Contribution

The paper reviews AR's potential in radiology and highlights the need to address monopolization risks by consumer tech firms.

## Key findings

- AR has potential to revolutionize radiology by projecting medical images onto real-world environments.
- Current AR development is dominated by major commercial tech firms, limiting clinical accessibility.
- The release of new AR headsets in 2024 calls for a reevaluation of AR's role and risks in radiology.

## Abstract

Augmented reality (AR) exists on a spectrum, a mixed reality hybrid of virtual projections onto real surroundings. Superimposing conventional medical imaging onto the living patient offers vast potential for radiology, potentially revolutionising practice. The digital technology and user-interfaces that allow us to appreciate this enhanced environment however are complex, expensive, and development mainly limited to major commercial technology (Tech) firms. Hence, it is the activity of these consumer-based businesses that will inevitably dictate the available technology and therefore clinical application of AR. The release of mixed reality head-mounted displays in 2024, must therefore prompt a review of the current status of AR research in radiology, the need for further study and a discussion of the complicated relationship between consumer technology, clinical utility, and the risks of monopolisation.